Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Yusha Guo"'
Autor:
Peng Ke, Jundan Xie, Ting Xu, Meiyu Chen, Yusha Guo, Ying Wang, Huiying Qiu, Depei Wu, Zhao Zeng, Suning Chen, Xiebing Bao
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundSatisfactory responses can be obtained for acute myeloid leukemia (AML) treated by Venetoclax (VEN)-based therapy. However, there are still quite a few AML patients (AMLs) resistant to VEN, and it is critical to understand whether VEN-resis
Externí odkaz:
https://doaj.org/article/c6ce763ab9a84e0f871224f0e948d099
Autor:
Wenjing Ding, Guangyang Weng, Zheng Wang, Yusha Guo, Man Wang, Hongjie Shen, Suning Chen, Xin Du, Lijun Wen
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
Acute promyelocytic leukemia (APL) is a special subtype of acute myeloid leukemia (AML), 95% patients have PML-RARA fusion gene as a result of a reciprocal chromosomal translocation t(15;17)(q22; q21). The retinoic acid receptors (RARs) belong to nuc
Externí odkaz:
https://doaj.org/article/d6579aa3acec43c0801e1084a5cf4690
Autor:
Peng Ke, Jundan Xie, Ting Xu, Meiyu Chen, Yusha Guo, Ying Wang, Huiying Qiu, Depei Wu, Zhao Zeng, Suning Chen, Xiebing Bao
Publikováno v:
Frontiers in Oncology; 2023, p1-17, 17p
Publikováno v:
International Journal of Clinical Medicine. 13:461-467
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a071ebc0743bd9802096affcc79c3a83
https://doi.org/10.4236/ijcm.2022.1310033
https://doi.org/10.4236/ijcm.2022.1310033